BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 25661370)

  • 1. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
    Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
    Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level.
    Kwon OH; Kang TW; Kim JH; Kim M; Noh SM; Song KS; Yoo HS; Kim WH; Xie Z; Pocalyko D; Kim SY; Kim YS
    Biochem Biophys Res Commun; 2012 Jun; 423(1):38-44. PubMed ID: 22627140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions.
    Bi YH; Han WQ; Li RF; Wang YJ; Du ZS; Wang XJ; Jiang Y
    World J Gastroenterol; 2019 Apr; 25(16):1936-1949. PubMed ID: 31086462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECM1 promotes the Warburg effect through EGF-mediated activation of PKM2.
    Lee KM; Nam K; Oh S; Lim J; Lee T; Shin I
    Cell Signal; 2015 Feb; 27(2):228-35. PubMed ID: 25446258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation.
    Azoitei N; Becher A; Steinestel K; Rouhi A; Diepold K; Genze F; Simmet T; Seufferlein T
    Mol Cancer; 2016 Jan; 15():3. PubMed ID: 26739387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
    Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
    J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
    Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1α/PKM2 pathway.
    Wang Q; Lu D; Fan L; Li Y; Liu Y; Yu H; Wang H; Liu J; Sun G
    Int J Mol Med; 2019 Jan; 43(1):475-488. PubMed ID: 30365092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids.
    Menrad H; Werno C; Schmid T; Copanaki E; Deller T; Dehne N; Brüne B
    Hepatology; 2010 Jun; 51(6):2183-92. PubMed ID: 20513003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated glucose metabolism.
    Wang HJ; Hsieh YJ; Cheng WC; Lin CP; Lin YS; Yang SF; Chen CC; Izumiya Y; Yu JS; Kung HJ; Wang WC
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):279-84. PubMed ID: 24344305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
    Hu W; Lu SX; Li M; Zhang C; Liu LL; Fu J; Jin JT; Luo RZ; Zhang CZ; Yun JP
    Oncotarget; 2015 Mar; 6(9):6570-83. PubMed ID: 25788265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.
    Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB
    Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyruvate Kinase M2 Knockdown Suppresses Migration, Invasion, and Epithelial-Mesenchymal Transition of Gastric Carcinoma via Hypoxia-Inducible Factor Alpha/B-Cell Lymphoma 6 Pathway.
    Li N; Meng D; Xu Y; Gao L; Shen F; Tie X; Zhang Y; Yi Z; Shen W; Liu Z; Xu Z
    Biomed Res Int; 2020; 2020():7467104. PubMed ID: 33376737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma.
    de Andrade Barreto E; de Souza Santos PT; Bergmann A; de Oliveira IM; Wernersbach Pinto L; Blanco T; Rossini A; Pinto Kruel CD; Mattos Albano R; Ribeiro Pinto LF
    Exp Mol Pathol; 2016 Aug; 101(1):66-73. PubMed ID: 27260309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-3-3ζ up-regulates hypoxia-inducible factor-1α in hepatocellular carcinoma via activation of PI3K/Akt/NF-кB signal transduction pathway.
    Tang Y; Lv P; Sun Z; Han L; Luo B; Zhou W
    Int J Clin Exp Pathol; 2015; 8(12):15845-53. PubMed ID: 26884855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase.
    Gao X; Wang H; Yang JJ; Liu X; Liu ZR
    Mol Cell; 2012 Mar; 45(5):598-609. PubMed ID: 22306293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
    Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
    Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear accumulation of pyruvate kinase M2 promotes liver regeneration via activation of signal transducer and activator of transcription 3.
    Hu K; Xu J; Fan K; Zhou D; Li L; Tang L; Peng X; Zhang L; Wang Y
    Life Sci; 2020 Jun; 250():117561. PubMed ID: 32198052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1α activation under glucose deprivation plays a central role in the acquisition of anti-apoptosis in human colon cancer cells.
    Nishimoto A; Kugimiya N; Hosoyama T; Enoki T; Li TS; Hamano K
    Int J Oncol; 2014 Jun; 44(6):2077-84. PubMed ID: 24718784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.